Technical Analysis for ACUR - Acura Pharmaceuticals, Inc.
Trend Table & Recent Alerts
|Weak or Absent||Down||Down||Up|
|See historical ACUR trend table...|
|Date||Alert Name||Type||% Chg|
|Apr 26||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Apr 25||NR7||Range Contraction||10.28%|
|Apr 25||Narrow Range Bar||Range Contraction||10.28%|
|Apr 25||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||10.28%|
|Apr 24||Bollinger Band Squeeze||Range Contraction||11.32%|
|Apr 24||180 Bearish Setup||Bearish Swing Setup||11.32%|
|Apr 21||Bollinger Band Squeeze||Range Contraction||0.00%|
|Apr 20||Bollinger Band Squeeze||Range Contraction||9.26%|
|Apr 20||180 Bearish Setup||Bearish Swing Setup||9.26%|
|Apr 19||Bollinger Band Squeeze||Range Contraction||0.00%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
- Earnings date: 2017-05-01
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies. Its products include Oxecta Tablets CII, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed, an over-the-counter immediate-release pseudoephedrine HCl tablet that is used as a nasal decongestant in various non-prescription and prescription cold, sinus, and allergy products. The company has seven additional opioid products utilizing Aversion technology in various stages of development. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc., a wholly-owned subsidiary of Pfizer Inc. to develop and commercialize certain opioid analgesic products utilizing the companys proprietary Aversion technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.
Is ACUR a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ACUR news...
|52 Week High||3.39|
|52 Week Low||0.46|
|200-Day Moving Average||1.0912|
|50-Day Moving Average||0.5941|
|20-Day Moving Average||0.5668|
|10-Day Moving Average||0.5655|
|Average True Range||0.0633|
|Chandelier Exit (Long, 3 ATRs)||0.4601|
|Chandelier Exit (Short, 3 ATRs)||0.7099|
|Upper Bollinger Band||0.6152|
|Lower Bollinger Band||0.5184|
|Percent B (%b)||0.74|